Atossa Genetics Stock In The News

ATOS Stock  USD 1.28  0.06  4.92%   
Our overall analysis of Atossa Genetics' news coverage and content from conventional and social sources shows investors' bearish mood towards Atossa Genetics. The specific impact of Atossa Genetics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Atossa Genetics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Atossa Genetics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Atossa Genetics Backtesting and Atossa Genetics Hype Analysis.
For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.

Atossa Genetics Today Top News and Investor Outlook

Yahoo News
3 Dirt-Cheap Drug Developers With Blockbuster Potential
https://finance.yahoo.com/news/3-dirt-cheap-drug-developers-110000436.html
 Neutral
Yahoo News
3 Penny Stock Moonshots with 300%+ Upside Potential by 2025
https://finance.yahoo.com/news/3-penny-stock-moonshots-300-134500633.html
 Bullish
Yahoo News
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar
https://finance.yahoo.com/news/meme-mania-meets-medicine-3-113000616.html
 Neutral
Yahoo News
3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off
https://finance.yahoo.com/news/3-must-buy-biotech-stocks-100000326.html
 Bullish
Yahoo News
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
https://finance.yahoo.com/news/wall-street-favorites-3-biotech-101500348.html
 Bullish
Yahoo News
Catalyst Countdown: 3 Biotech Stocks With Upcoming News That Could Move the Market
https://finance.yahoo.com/news/catalyst-countdown-3-biotech-stocks-205745143.html
 Bullish
Macroaxis News: globenewswire.com
Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial
https://www.globenewswire.com/news-release/2023/11/20/2783241/0/en/Atossa-Therapeutics-Announces-Full-Enrollment-of-Phase-2-Karisma-Endoxifen-Clinical-Trial.html
 Neutral
Macroaxis News: globenewswire.com
Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
https://www.globenewswire.com/news-release/2023/11/13/2779093/0/en/Atossa-Therapeutics-Announces-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
 Bullish
Macroaxis News: globenewswire.com
Atossa Therapeutics Appoints Financial Executive Jonathan Finn to its Board of Directors
https://www.globenewswire.com/news-release/2023/11/09/2777412/0/en/Atossa-Therapeutics-Appoints-Financial-Executive-Jonathan-Finn-to-its-Board-of-Directors.html
 Bullish
Macroaxis News: globenewswire.com
Atossa to Present at Cantor Fitzgerald Global Healthcare Conference 2023
https://www.globenewswire.com/news-release/2023/09/18/2744769/0/en/Atossa-to-Present-at-Cantor-Fitzgerald-Global-Healthcare-Conference-2023.html
 Neutral

Atossa Genetics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Atossa and other traded companies coverage with news coverage. We help investors stay connected with Atossa headlines for the 25th of November to make an informed investment decision based on correlating the impacts of news items on Atossa Stock performance. Please note that trading solely based on the Atossa Genetics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Atossa Genetics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Atossa Genetics investors visualize upcoming and past events in order to time the market based on Atossa Genetics noise-free hype analysis.
Atossa Genetics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Atossa earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Atossa Genetics that are available to investors today. That information is available publicly through Atossa media outlets and privately through word of mouth or via Atossa internal channels. However, regardless of the origin, that massive amount of Atossa data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Atossa Genetics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Atossa Genetics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Atossa Genetics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Atossa Genetics alpha.

Atossa Largest EPS Surprises

Earnings surprises can significantly impact Atossa Genetics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-12
2024-06-30-0.06-0.050.0116 
2023-05-15
2023-03-31-0.06-0.050.0116 
2022-08-08
2022-06-30-0.06-0.050.0116 
2022-05-09
2022-03-31-0.05-0.040.0120 
2021-05-14
2021-03-31-0.05-0.040.0120 
2024-05-13
2024-03-31-0.07-0.050.0228 
View All Earnings Estimates

Atossa Genetics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Atossa Genetics Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
Gurufocus Stories at Macroaxis
21st of November 2024
Atossa Therapeutics to Present Poster on -Endoxifen at AACR Special Conference in Cancer R...
at gurufocus.com 
Yahoo News
20th of November 2024
Atossa Therapeutics Announces Five Abstracts Highlighting -Endoxifen Research Accepted for...
at finance.yahoo.com 
Investing News at Macroaxis
13th of November 2024
Atossa Genetics stock target lifted, retains buy on positive study results
at investing.com 
Yahoo News
5th of November 2024
Atossa Therapeutics Appoints Claudia Lopez, DVM, MSc, as Vice President, Clinical Product ...
at finance.yahoo.com 
news
1st of November 2024
HC Wainwright Reiterates Buy Rating for Atossa Therapeutics
at thelincolnianonline.com 
Yahoo News
28th of October 2024
Are Medical Stocks Lagging Atossa Genetics This Year
at finance.yahoo.com 
Macroaxis News: globenewswire.com
25th of October 2024
US District Court for the Southern District of New York orders a new trial on compensatory...
at globenewswire.com 
Yahoo News
15th of October 2024
Atos appoints Philippe Salle as new chairman and CEO
at finance.yahoo.com 
Yahoo News
16th of September 2024
Availability of the adjusted draft accelerated safeguard plan
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Atossa Genetics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Atossa Genetics' short interest history, or implied volatility extrapolated from Atossa Genetics options trading.

Additional Tools for Atossa Stock Analysis

When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.